JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Anterolateral ankle impingement: diagnostic performance of MDCT arthrography and sonography.

OBJECTIVE: The purpose of our study was to compare the diagnostic performance of CT arthrography and sonography in the diagnosis of anterolateral ankle impingement.

SUBJECTS AND METHODS: Fifty-one patients with clinically suspected anterolateral ankle impingement prospectively underwent ankle sonography and CT arthrography, immediately followed by an additional ankle sonography examination to evaluate a potential joint effusion impact on diagnostic performance. CT arthrographic findings as well as sonographic findings before and after arthrography were correlated to subsequent arthroscopic appearance in 41 patients. The diagnostic performance of CT arthrography and sonography before and after joint injection was calculated using arthroscopy as the reference standard and compared using McNemar tests.

RESULTS: The sensitivity and specificity of sonography were respectively 77% and 57% before joint injection and 85% and 71% after joint injection. Positive Doppler masses were found to be anterolateral impingements at arthroscopy in all cases (10/10), and masses of hyperechoic appearance were found not to be anterolateral impingements in all cases (3/3). The sensitivity and specificity of CT arthrography in the diagnosis of anterolateral impingement were respectively 97% and 71%. The performances of CT arthrography and ankle sonography in the diagnosis of anterolateral ankle impingement were significantly different (p = 0.006).

CONCLUSION: CT arthrography is quite accurate and superior to ankle sonography in the diagnosis of anterolateral impingement. The diagnostic performance of sonography is limited, but positive Doppler appearance and hyperechogenicity, when present, could help to exclude or confirm the diagnosis.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app